nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A better crystal ball to predict lung-cancer survival?
|
Onn, Amir |
|
2006 |
7 |
10 |
p. 789-790 2 p. |
artikel |
2 |
Added dimensions to lung-cancer treatment
|
Bagchi, Sanjit |
|
2006 |
7 |
10 |
p. 802- 1 p. |
artikel |
3 |
Appraisal of bevacizumab and cetuximab for treatment of metastatic colorectal cancer in the UK
|
Barnett, David |
|
2006 |
7 |
10 |
p. 807-808 2 p. |
artikel |
4 |
Brain-cancer link with lead exposure in workplace
|
Bosch, Xavier |
|
2006 |
7 |
10 |
p. 805- 1 p. |
artikel |
5 |
Breast reconstruction compromises radiotherapy planning
|
Mayor, Susan |
|
2006 |
7 |
10 |
p. 803- 1 p. |
artikel |
6 |
Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine
|
Landriscina, Matteo |
|
2006 |
7 |
10 |
p. 877-879 3 p. |
artikel |
7 |
Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer
|
Kwock, Lester |
|
2006 |
7 |
10 |
p. 859-868 10 p. |
artikel |
8 |
Erlotinib improves quality of life
|
Susman, Ed |
|
2006 |
7 |
10 |
p. 802- 1 p. |
artikel |
9 |
Errata
|
|
|
2006 |
7 |
10 |
p. 797- 1 p. |
artikel |
10 |
Errata
|
|
|
2006 |
7 |
10 |
p. 797- 1 p. |
artikel |
11 |
Errata
|
|
|
2006 |
7 |
10 |
p. 797- 1 p. |
artikel |
12 |
Finasteride: not guilty after all?
|
Powledge, Tabitha M |
|
2006 |
7 |
10 |
p. 800- 1 p. |
artikel |
13 |
Global cost of cancer
|
Lyman, Gary |
|
2006 |
7 |
10 |
p. 809-810 2 p. |
artikel |
14 |
GRP78 as potential predictor of chemoresistance
|
Sharma, Sharan Prakash |
|
2006 |
7 |
10 |
p. 800- 1 p. |
artikel |
15 |
High-dose chemotherapy in children with newly-diagnosed medulloblastoma
|
Grill, Jacques |
|
2006 |
7 |
10 |
p. 787-789 3 p. |
artikel |
16 |
Image-guided radiotherapy: rationale, benefits, and limitations
|
Dawson, Laura A |
|
2006 |
7 |
10 |
p. 848-858 11 p. |
artikel |
17 |
Imatinib helps elderly patients with leukaemia
|
Bradbury, Jane |
|
2006 |
7 |
10 |
p. 803- 1 p. |
artikel |
18 |
Is a radiotherapy boost truly beneficial?
|
Stillie, Alison |
|
2006 |
7 |
10 |
p. 795-796 2 p. |
artikel |
19 |
Is a radiotherapy boost truly beneficial? – Author's reply
|
Gruber, Guenther |
|
2006 |
7 |
10 |
p. 796-797 2 p. |
artikel |
20 |
Keynote comment: Radiotherapy in the age of molecular oncology
|
Baumann, Michael |
|
2006 |
7 |
10 |
p. 786-787 2 p. |
artikel |
21 |
Molecular imaging in diagnosis of neuroendocrine tumours
|
Oberg, Kjell |
|
2006 |
7 |
10 |
p. 790-792 3 p. |
artikel |
22 |
Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response
|
Jones, Robin L |
|
2006 |
7 |
10 |
p. 869-874 6 p. |
artikel |
23 |
News in brief
|
|
|
2006 |
7 |
10 |
p. 806- 1 p. |
artikel |
24 |
New test better than immunohistochemistry?
|
Kerr, Cathel |
|
2006 |
7 |
10 |
p. 799- 1 p. |
artikel |
25 |
New uniform response criteria for multiple myeloma
|
Furlow, Bryant |
|
2006 |
7 |
10 |
p. 805- 1 p. |
artikel |
26 |
No benefit of OSI-7904L for gastro-oesophageal cancer
|
Taylor, Rosie |
|
2006 |
7 |
10 |
p. 801- 1 p. |
artikel |
27 |
One for sorrow, two for joy, and three for hope
|
Tilstone, Claire |
|
2006 |
7 |
10 |
p. 809- 1 p. |
artikel |
28 |
Online cancer-risk assessment—is it really that easy?
|
Senior, Kathryn |
|
2006 |
7 |
10 |
p. 810-811 2 p. |
artikel |
29 |
Pelvic exenteration for gynaecological tumours: achievements and unanswered questions
|
Höckel, Michael |
|
2006 |
7 |
10 |
p. 837-847 11 p. |
artikel |
30 |
Phyllodes breast tumour showing invasive squamous-cell carcinoma with invasive ductal, clear-cell, secretory, and squamous components
|
Ramdass, Michael J |
|
2006 |
7 |
10 |
p. 880- 1 p. |
artikel |
31 |
Preimplantation genetic diagnosis for cancer
|
Niermeijer, Martinus F |
|
2006 |
7 |
10 |
p. 794-795 2 p. |
artikel |
32 |
Reinvention
|
The Lancet Oncology, |
|
2006 |
7 |
10 |
p. 785- 1 p. |
artikel |
33 |
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
|
Gajjar, Amar |
|
2006 |
7 |
10 |
p. 813-820 8 p. |
artikel |
34 |
Risks and benefits of chloroquine use in anticancer strategies
|
Savarino, Andrea |
|
2006 |
7 |
10 |
p. 792-793 2 p. |
artikel |
35 |
Schlafer
|
Burki, Talha |
|
2006 |
7 |
10 |
p. 811-812 2 p. |
artikel |
36 |
Sirolimus monotherapy for Kaposi's sarcoma in an HIV-negative patient
|
Weenink, Jan J |
|
2006 |
7 |
10 |
p. 875-876 2 p. |
artikel |
37 |
Speeding up cancer-drug development
|
Burton, Adrian |
|
2006 |
7 |
10 |
p. 798- 1 p. |
artikel |
38 |
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study
|
Rocca, Walter A |
|
2006 |
7 |
10 |
p. 821-828 8 p. |
artikel |
39 |
Survivors of childhood cancer and suicide
|
Nelson, Roxanne |
|
2006 |
7 |
10 |
p. 801- 1 p. |
artikel |
40 |
TNFα antagonist not associated with increased cancer risk
|
Tilstone, Claire |
|
2006 |
7 |
10 |
p. 804- 1 p. |
artikel |
41 |
Topotecan adds no benefit in advanced ovarian cancer
|
Gould, Paula |
|
2006 |
7 |
10 |
p. 799- 1 p. |
artikel |
42 |
Treatment success against stubborn lymphoid cancers
|
Senior, Kathryn |
|
2006 |
7 |
10 |
p. 804- 1 p. |
artikel |
43 |
4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index
|
Blanchon, François |
|
2006 |
7 |
10 |
p. 829-836 8 p. |
artikel |